Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR663453

GTEX

b74b7059-5a4c-550b-b5e1-f7b3052e4e06

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Female

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • PROTEIN_SECRETION+0.280
  • MYC_TARGETS_V1+0.166
  • UNFOLDED_PROTEIN_RESPONSE+0.161
  • DNA_REPAIR+0.157
  • MITOTIC_SPINDLE+0.092
  • PI3K_AKT_MTOR_SIGNALING+0.063
  • OXIDATIVE_PHOSPHORYLATION+0.057
  • HEME_METABOLISM-0.007
  • MYC_TARGETS_V2-0.013
  • UV_RESPONSE_UP-0.050

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.552
  • INFLAMMATORY_RESPONSE-0.496
  • COAGULATION-0.485
  • INTERFERON_GAMMA_RESPONSE-0.476
  • ANGIOGENESIS-0.473
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.462
  • TNFA_SIGNALING_VIA_NFKB-0.450
  • IL6_JAK_STAT3_SIGNALING-0.447
  • NOTCH_SIGNALING-0.437
  • ALLOGRAFT_REJECTION-0.397

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1321244
brain-umap@2
GTEX0.986
2SRR1351325
brain-umap@2
GTEX0.986
3SRR1374246
brain-umap@2
GTEX0.986
4SRR1343115
brain-umap@2
GTEX0.984
5SRR1410934
brain-umap@2
GTEX0.983
6SRR1406917
brain-umap@2
GTEX0.982
7SRR1421140
brain-umap@2
GTEX0.981
8SRR819999
brain-umap@2
GTEX0.980
9SRR599225
brain-umap@2
GTEX0.979
10SRR1429891
brain-umap@2
GTEX0.979

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 7 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PROTEIN_SECRETION0.280Remibrutinib— uncovered
MYC_TARGETS_V10.166Inavolisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.161Idelalisib— uncovered
DNA_REPAIR0.157Idelalisib— uncovered
MITOTIC_SPINDLE0.092Inavolisib— uncovered
PI3K_AKT_MTOR_SIGNALING0.063Inavolisib— uncovered
OXIDATIVE_PHOSPHORYLATION0.057Remibrutinib— uncovered